These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15811577)

  • 1. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
    He Q; Riley RT; Sharma RP
    Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
    He Q; Kim J; Sharma RP
    Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.
    He Q; Riley RT; Sharma RP
    Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
    Rentz SS; Showker JL; Meredith FI; Riley RT
    Food Chem Toxicol; 2005 Jan; 43(1):123-31. PubMed ID: 15582204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
    Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
    Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver.
    He Q; Johnson VJ; Osuchowski MF; Sharma RP
    Mycopathologia; 2004 Apr; 157(3):339-47. PubMed ID: 15180163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH; van Echten G; Wang E; Sandhoff K
    J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.
    Sharma RP; He Q; Riley RT
    Toxicology; 2005 Dec; 216(1):59-71. PubMed ID: 16159691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
    He Q; Riley RT; Sharma RP
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride.
    He Q; Kim J; Sharma RP
    Toxicology; 2005 Feb; 207(1):137-47. PubMed ID: 15590129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-adenosylmethionine or 5'-methylthioadenosine are unable to prevent fumonisin B1 hepatotoxicity in mice despite increased oxidation in liver.
    He Q; Suzuki H; Sharma RP
    J Appl Toxicol; 2006; 26(6):509-16. PubMed ID: 17080400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and transient activation of protein kinase C alpha by fumonisin B1, a ceramide synthase inhibitor mycotoxin, in cultured porcine renal cells.
    Gopee NV; Sharma RP
    Life Sci; 2004 Feb; 74(12):1541-59. PubMed ID: 14729403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
    He Q; Sharma RP
    Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
    Gopee NV; Sharma RP
    Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
    Tsunoda M; Sharma RP; Riley RT
    J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
    Suzuki H; Riley RT; Sharma RP
    Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier.
    Osuchowski MF; He Q; Sharma RP
    Food Chem Toxicol; 2005 Sep; 43(9):1389-97. PubMed ID: 15913876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of IFN-gamma reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors.
    Sharma RP; He Q; Johnson VJ
    J Interferon Cytokine Res; 2003 Jan; 23(1):13-23. PubMed ID: 12639295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
    Yoo HS; Norred WP; Showker J; Riley RT
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.